Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 37.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 74.00
  • 52 Week Low: 31.50
  • Currency: UK Pounds
  • Shares Issued: 43.87m
  • Volume: 0
  • Market Cap: £16.45m
  • RiskGrade: 240

Regulatory News

Cancellation and Grant of Options 19-Jun-2020 11:00 RNS
Result of AGM 10-Jun-2020 12:30 RNS
Grant awarded for Cardiff University collaboration 09-Jun-2020 07:00 RNS
Posting of Annual Report and Notice of AGM 12-May-2020 15:15 RNS
Independent review supports the potential of XF-73 04-May-2020 07:00 RNS
Final Results 29-Apr-2020 07:00 RNS
Notice of Results 24-Apr-2020 07:00 RNS
Clinical and Business Update 03-Mar-2020 07:00 RNS
Directorate Change 02-Dec-2019 07:00 RNS
Destiny to present at UK-China AMR Workshop 02-Dec-2019 07:00 RNS
Directorate Change 23-Sep-2019 07:00 RNS
Interim Results for 6 months ended 30 June 2019 23-Sep-2019 07:00 RNS
Notice of Results 12-Sep-2019 07:00 RNS
Holding(s) in Company 15-Aug-2019 12:20 RNS
Holding(s) in Company 19-Jul-2019 15:12 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 37.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 74.00
52 Week Low 31.50
Volume 0
Shares Issued 43.87m
Market Cap £16.45m
RiskGrade 240

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.26% below the market average20.26% below the market average20.26% below the market average20.26% below the market average20.26% below the market average
7.14% above the sector average7.14% above the sector average7.14% above the sector average7.14% above the sector average7.14% above the sector average
Price Trend
53.24% below the market average53.24% below the market average53.24% below the market average53.24% below the market average53.24% below the market average
78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average
Income Not Available
Growth Not Available

Destiny Pharma Dividends

No dividends found

Trades for --2020

Time Volume / Share Price
0 @ 0.000p

Destiny Pharma Key Personnel

CEO Neil Clark
Chair Nick Rodgers

Top of Page